Analysis: Ellenbarrie Industrial Gases Ltd

Growth thesis

Ellenbarrie Industrial Gases produces oxygen, nitrogen, and argon through on-site and merchant air separation plants, with steel contributing roughly one third of revenue and the balance spread across chemicals, pharmaceuticals, healthcare, and other manufacturing. It operates as an independent player against Linde, Inox, and Air Products, each at least five times its size, and holds a mid-single-digit share of India's industrial gas market. In Q1 FY27, core gases revenue was ₹973 million, up 20% year on year, and the EBITDA margin reached 39%, up from 38% a year ago. That margin has remained above 35% for two consecutive fiscal years, a level that indicates genuine pricing power and cost discipline rather than commodity supply.

The persistence of these economics rests on structural barriers that are not easily replicated. On-site plants operate under long term take or pay contracts, typically fifteen years, which fix revenue and physically tie the customer to the plant. Merchant plants benefit from transportation economics that limit competition to a 300 to 400 kilometer radius, giving well placed plants local pricing power. The company designs and executes its own plants, including units up to 1,000 tons per day, which shortens lead times and reduces capital cost per ton, an advantage only the largest multinationals possess. Argon, a byproduct of oxygen, has a demand supply gap in specialty steel and solar cell manufacturing, and the company is increasingly signing longer term argon agreements to reduce price volatility. These factors explain why margins have held near 40% despite soft argon prices and steel sector weakness.

The inflection point is the current capacity expansion wave. Uluberia 2, a 220 ton per day merchant plant, was commissioned in Q4 FY26 and is ramping through FY27, with a typical 18 month path to 85% utilization. The East India on-site plant of 320 tons per day began contributing revenue in Q2 FY27, as confirmed on the August 2026 call. Construction has started on two merchant plants, 220 tons per day in North India and 250 tons per day in West Central India, targeted for commission in H2 FY27 and early FY28 respectively. By FY28, merchant capacity is expected to rise from roughly 900 to about 1,350 tons per day, and on-site capacity from 700 to about 1,000 tons per day. This roughly 50% capacity increase, combined with operating leverage from newer power efficient plants and a renewable energy PPA covering 55 to 60% of one factory's power demand, should support a 20% revenue CAGR while EBITDA margins hold at 40% or better. The on-site inquiry pipeline exceeds 600 tons per day, which would add further scale beyond the current plan.

Management has consistently delivered against its stated milestones. On the May 2026 call, it guided to the East India plant going live in June 2026, and the August 2026 call confirmed revenue contribution from Q2 FY27, a slip of less than a quarter. Uluberia 2 was commissioned in Q4 FY26 as promised, and the Kurnool plant is ramping. EBITDA margin improved from 38.4% in FY26 to 39% in Q1 FY27, in line with the 40% target, while PAT rose 87% year on year to ₹350 million, aided by lower finance costs and a lower effective tax rate. Capex guidance of ₹2,500 million for FY27 and ₹2,000 million for FY28 has been reaffirmed, and the company held net cash of ₹3,550 million as of February 2026, indicating no dilution risk. Management has not cut guidance and has repeated the 20% revenue CAGR target across four consecutive quarters.

The earnings path over the next 18 to 24 months is clear. Annualized revenue from the Q1 FY27 run rate of roughly ₹3.9 billion, growing at 20% per year, would reach approximately ₹5.6 billion by mid-2028. With EBITDA margin at 40%, that implies EBITDA of about ₹2.2 billion, up from the current annualized run rate of roughly ₹1.5 billion. The key assumption is that the new merchant plants reach 80 to 90% utilization within 18 to 24 months of commissioning, which is the standard ramp profile but carries execution risk because merchant plants have no advance orders. The single most important watchpoint is the demand pull from the micro markets in North and West Central India; if those plants take longer to fill or argon prices remain below H1 FY26 levels, margins could dip quarterly even if the structural trend holds. The tension between PAT rising 87% and gross margin only improving 100 basis points is explained by finance cost and tax effects, not operational weakness, so the operational story is intact. The falsifier would be a delay in commissioning of the North India or West Central plants beyond one quarter, or a sustained drop in argon pricing that pushes blended margins below 35% for two consecutive quarters.

Research report

companyname: Ellenbarrie Industrial Gases Limited ticker: ELLEN sector: Industrial Gases Ellenbarrie Industrial Gases Limited separates air into oxygen, nitrogen, and argon at cryogenic air separation units, then sells those gases, plus a wider portfolio (carbon dioxide, helium, acetylene, hydrogen, nitrous oxide, synthetic air, and ultra-high-purity specialty gases), to factories and hospitals across India. It is a fully Indian-owned company with a 50-year history, incorporated in 1973. Japan'...